<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="generator" content="pandoc">
  <meta name="author" content="Ryan A. Robinett, Ning Guan, Aaron S. Meyer">
  <title>Dissecting FcγR Regulation Through a Multivalent Binding Model</title>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
  <![endif]-->
  <link rel="stylesheet" href="./Templates/kultiad.css">
</head>
<body>
<header>

<h1 class="title">Dissecting FcγR Regulation Through a Multivalent Binding Model</h1>


<h2 class="author"></h2>
<p class="affilation"><em></em></p>

</header>


<p class="small"><strong>Abstract: </strong><em>Many immune receptors transduce activation across the plasma membrane through their clustering. In the case of Fcγ receptors, this clustering is usually driven by binding to antibodies of differing affinity in turn bound to multivalent antigen. As a consequence of this activation mechanism, accounting for and rationally manipulating IgG effector function is complicated by, among other factors, the contribution of differing affinities to multiple FcγRs and changes in the valency of antigen binding. In this study, we show that a model of multivalent receptor-ligand binding can effectively account for the contribution of IgG-FcγR affinity and immune complex valency. This model in turn enables us to make specific predictions about the effect of immune complexes of defined composition. In total, these results enable rationally designed IgG effector function, or deconvolution of function, in both a forward and reverse manner.</em></p>



<h1 id="introduction">Introduction</h1>
<p>Antibodies are critical and central regulators of the immune response. Antibodies of the IgG isotype interact with FcγR receptors expressed widely on innate immune effector cells. Regulation of effector cell function is a critical component of the IgG therapy's use in cancer and autoimmune diseases. Effector function operates through multiple cell types—including macrophages, monocytes, neutrophils, and NK cells—and multiple process such as antibody-dependent cell-mediated cytotoxicity (ADCC), promoting antigen presentation, and cytokine response. In addition to their effect in isolation, IgG therapies can show synergistic effect in cancers in combination with checkpoint and cytokine-mediated immunotherapies<span class="citation" data-cites="Moynihan:2016jb"><sup><a href="#ref-Moynihan:2016jb">1</a></sup></span><span class="citation" data-cites="Zhu:2015gy"><sup><a href="#ref-Zhu:2015gy">2</a></sup></span>. These immunotherapeutic effects in combination with antibodies' ability to operate as signaling modulators through competitive binding and opsonization make IgG biologic agents particularly versatile therapeutic agents.</p>
<p>An ability to quantitatively predict IgG-FcγR function would aid understanding and treatment of cancer and autoimmune diseases. Efforts to engineer improved effector responses to IgG treatment include mutated Fc variants with biased FcγR binding, deglycosylated Fc domains with the effect of modulating FcγR binding, and alternative IgG subclasses with distinct binding profiles. In addition, particularly in cases where antigen and antibody are exogenously provided, avidity and binding affinities may be manipulated coordinately.</p>
<p>Multiple efforts have sought to improve our understanding of IgG-mediated effector function. These include efforts to carefully quantify the individual, monovalent FcγR-IgG affinities<span class="citation" data-cites="Bruhns:2009kg"><sup><a href="#ref-Bruhns:2009kg">3</a></sup></span>. In addition, previous studies have characterized the effects of IgG glycosylation (which serves to modulate FcγR affinity) and immune complex avidity on the binding of IgG-antigen complexes<span class="citation" data-cites="Lux:2013iv"><sup><a href="#ref-Lux:2013iv">4</a></sup></span>. Genetic models have made it possible to remove certain FcγRs and examine the consequent effect on IgG treatment in various cancer models<span class="citation" data-cites="Clynes:2000ga"><sup><a href="#ref-Clynes:2000ga">5</a></sup></span>. Finally, comparison of antibodies with matched variable regions but differing Fc domains has allowed the effects to be compared, through with necessarily pleiotropic differences between each of these classes<span class="citation" data-cites="Nimmerjahn:2005hu"><sup><a href="#ref-Nimmerjahn:2005hu">6</a></sup></span>.</p>
<p>Models of multivalent ligand binding to monovalent receptors have been successfully employed to study function of other immune receptors with known, corresponding binding models<span class="citation" data-cites="Perelson:1980fs"><sup><a href="#ref-Perelson:1980fs">7</a></sup></span><span class="citation" data-cites="Perelson:1980ds"><sup><a href="#ref-Perelson:1980ds">8</a></sup></span><span class="citation" data-cites="Hlavacek:1999gb"><sup><a href="#ref-Hlavacek:1999gb">9</a></sup></span>. For example, a two-component binding model can capture the effect of T cell receptor activation<span class="citation" data-cites="Stone:2001fm"><sup><a href="#ref-Stone:2001fm">10</a></sup></span>. However, the FcγR family presents the considerable additional challenge of multiple distinct receptor classes being expressed simultaneously within cells. Additionally, the multiple FcγRs present, with activating and inhibitory roles, ensure that any manipulation of immune complex composition will necessarily have multivariate effects. The same challenge exists for other paired receptor-ligand families, including other immunoglobulin classes and the many phosphatidylserine receptors. Thus, while the underlying theoretical models of multivalent binding are long-standing, FcγR-IgG interactions are especially suited for developments in the ability to rigorously link these models to experimental observations.</p>
<p>In this study, we have employed a model of multivalent immune complex binding to FcγR receptors and show that it can capture the experimentally measured binding at differing valencies. Applying this model, we show it can quantitatively predict effector response in response to diverse interventions in a forward manner, and can deconvolve the causal factors of response in a reverse fashion. More broadly, these results demonstrate the power of a unified binding model tied to computational inference techniques linking theory and experimental observation.</p>
<h1 id="results">Results</h1>
<h2 id="igg-fcγr-binding-varies-with-affinity-and-avidity">IgG-FcγR binding varies with affinity and avidity</h2>
<figure>
<embed src="./Figures/Figure1.pdf" id="fig:Binding" /><figcaption>Figure 1: FcγR binding changes with FcγR-IgG pair and avidity.</figcaption>
</figure>
<h2 id="a-multivalent-binding-model-accounts-for-variation-in-igg-fcγr-binding">A multivalent binding model accounts for variation in IgG-FcγR binding</h2>
<figure>
<embed src="./Figures/Figure1.pdf" id="fig:ModelFit" /><figcaption>Figure 2: Regression of the multivalent binding model to the FcγR binding data.</figcaption>
</figure>
<h2 id="subsection">Subsection</h2>
<h2 id="subsection-1">Subsection</h2>
<h1 id="discussion">Discussion</h1>
<h1 id="methods">Methods</h1>
<h2 id="data">Data</h2>
<p>All binding measurements were generously provided by Anja Lux of the Nimmerjahn Lab. Binding was measured using ELISA. The quantity of ligand bound in the original data is measured in terms of mean fluorescent intensity (MFI). Four replicates were used in the lab's assays. We normalized the data by replicate in our simulations.</p>
<p>% TODO: The binding data will need to be described in the level of detail Lux et al has since we will be including original data.</p>
<h2 id="equations">Equations</h2>
<p>The equilibrium binding of TNP-X-BSA to FcγRs was modeled using an equilibrium model of multivalent ligand binding to monovalent receptors expressed uniformly on a cell surface<span class="citation" data-cites="Stone:2001fm"><sup><a href="#ref-Stone:2001fm">10</a></sup></span>.</p>
<p>According to the model, the number of ligand bound <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>i</mi><annotation encoding="application/x-tex">i</annotation></semantics></math>-valently to the cell at equilibrium, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>v</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><annotation encoding="application/x-tex">v_{eq}</annotation></semantics></math>, can be found using the relation</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>v</mi><mrow><mi>i</mi><mo>,</mo><mi>e</mi><mi>q</mi></mrow></msub><mo>=</mo><mrow><mo stretchy="true" form="prefix">(</mo><mstyle linethickness="0"><mfrac><mi>v</mi><mi>i</mi></mfrac></mstyle><mo stretchy="true" form="postfix">)</mo></mrow><mo stretchy="false" form="prefix">(</mo><msub><mi>K</mi><mi>X</mi></msub><msup><mo stretchy="false" form="postfix">)</mo><mrow><mi>i</mi><mo>−</mo><mn>1</mn></mrow></msup><mfrac><msub><mi>L</mi><mn>0</mn></msub><msub><mi>K</mi><mi>D</mi></msub></mfrac><mo stretchy="false" form="prefix">(</mo><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><msup><mo stretchy="false" form="postfix">)</mo><mi>i</mi></msup></mrow><annotation encoding="application/x-tex"> v_{i,eq} = {v\choose i} (K_X)^{i-1} \frac{L_0}{K_D} (R_{eq})^i </annotation></semantics></math></p>
Here, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math> is a cross-linking constant with units of # per cell (for our purposes, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math> is assumed to be identical for all combinations of FcγR and IgG,) <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>L</mi><mn>0</mn></msub><annotation encoding="application/x-tex">L_0</annotation></semantics></math> is the concentration of ligand, and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><annotation encoding="application/x-tex">R_{eq}</annotation></semantics></math> is the number of receptors bound at equilibrium. Consequently,
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>L</mi><mrow><mi>b</mi><mi>o</mi><mi>u</mi><mi>n</mi><mi>d</mi></mrow></msub><mo>=</mo><munderover><mo>∑</mo><mrow><mi>i</mi><mo>=</mo><mn>1</mn></mrow><mi>v</mi></munderover><msub><mi>v</mi><mrow><mi>i</mi><mo>,</mo><mi>e</mi><mi>q</mi></mrow></msub><mo>=</mo><munderover><mo>∑</mo><mrow><mi>i</mi><mo>=</mo><mn>1</mn></mrow><mi>v</mi></munderover><mrow><mo stretchy="true" form="prefix">(</mo><mstyle linethickness="0"><mfrac><mi>v</mi><mi>i</mi></mfrac></mstyle><mo stretchy="true" form="postfix">)</mo></mrow><mo stretchy="false" form="prefix">(</mo><msub><mi>K</mi><mi>X</mi></msub><msup><mo stretchy="false" form="postfix">)</mo><mrow><mi>i</mi><mo>−</mo><mn>1</mn></mrow></msup><mfrac><msub><mi>L</mi><mn>0</mn></msub><msub><mi>K</mi><mi>D</mi></msub></mfrac><mo stretchy="false" form="prefix">(</mo><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><msup><mo stretchy="false" form="postfix">)</mo><mi>i</mi></msup><mo>,</mo></mrow><annotation encoding="application/x-tex">\begin{equation}
L_{bound} = \sum_{i=1}^{v} v_{i,eq} = \sum_{i=1}^{v} {v\choose i} (K_X)^{i-1} \frac{L_0}{K_D} (R_{eq})^i,
\end{equation}</annotation></semantics></math>
where <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>L</mi><mrow><mi>b</mi><mi>o</mi><mi>u</mi><mi>n</mi><mi>d</mi></mrow></msub><annotation encoding="application/x-tex">L_{bound}</annotation></semantics></math> is the total number of ligand bound at equilibrium and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>v</mi><annotation encoding="application/x-tex">v</annotation></semantics></math> is the effective avidity of the ligand. It is important to distinguish between the effective avidity and the actual avidity of a multivalent ligand, as steric effects might prevent such a ligand from binding to <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>v</mi><mrow><mi>a</mi><mi>c</mi><mi>t</mi><mi>u</mi><mi>a</mi><mi>l</mi></mrow></msub><annotation encoding="application/x-tex">v_{actual}</annotation></semantics></math> receptors at once. We will later show that this was the case in Lux's experiments. <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><annotation encoding="application/x-tex">R_{eq}</annotation></semantics></math> is a function of <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>v</mi><annotation encoding="application/x-tex">v</annotation></semantics></math>, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>L</mi><mn>0</mn></msub><annotation encoding="application/x-tex">L_0</annotation></semantics></math>, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>D</mi></msub><annotation encoding="application/x-tex">K_D</annotation></semantics></math>, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math>, and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>R</mi><mi>t</mi><mi>o</mi><mi>t</mi></mrow><annotation encoding="application/x-tex">Rtot</annotation></semantics></math>, the total number of receptors expressed on the cell surface, and can be approximated numerically using the following relationship when these parameters are known:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>R</mi><mrow><mi>t</mi><mi>o</mi><mi>t</mi></mrow></msub><mo>=</mo><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><mo minsize="1.8" maxsize="1.8" stretchy="false" form="prefix">(</mo><mn>1</mn><mo>+</mo><mi>v</mi><mfrac><msub><mi>L</mi><mn>0</mn></msub><msub><mi>K</mi><mi>D</mi></msub></mfrac><mo stretchy="false" form="prefix">(</mo><mn>1</mn><mo>+</mo><msub><mi>K</mi><mi>X</mi></msub><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><msup><mo stretchy="false" form="postfix">)</mo><mrow><mi>v</mi><mo>−</mo><mn>1</mn></mrow></msup><mo minsize="1.8" maxsize="1.8" stretchy="false" form="postfix">)</mo><mi>.</mi></mrow><annotation encoding="application/x-tex">\begin{equation}
R_{tot} = R_{eq} \Big(1+v \frac{L_0}{K_D} (1+K_X R_{eq})^{v-1}\Big).
\end{equation}</annotation></semantics></math>
Let <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><mo stretchy="false" form="prefix">(</mo><msub><mi>R</mi><mrow><mi>t</mi><mi>o</mi><mi>t</mi></mrow></msub><mo>,</mo><mi>v</mi><mo>,</mo><msub><mi>L</mi><mn>0</mn></msub><mo>,</mo><msub><mi>K</mi><mi>D</mi></msub><mo>,</mo><msub><mi>K</mi><mi>X</mi></msub><mo stretchy="false" form="postfix">)</mo></mrow><annotation encoding="application/x-tex">R_{eq}(R_{tot},v,L_0,K_D,K_X)</annotation></semantics></math> be the numerical approximation of <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>R</mi><mrow><mi>e</mi><mi>q</mi></mrow></msub><annotation encoding="application/x-tex">R_{eq}</annotation></semantics></math> given the parameters listed. Consequent of Equation (1), <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>R</mi><mrow><mi>m</mi><mi>u</mi><mi>l</mi><mi>t</mi><mi>i</mi></mrow></msub><annotation encoding="application/x-tex">R_{multi}</annotation></semantics></math>, the number of receptors that are clustered with at least one other receptor at equilibrium, can be found as follows:
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>R</mi><mrow><mi>m</mi><mi>u</mi><mi>l</mi><mi>t</mi><mi>i</mi></mrow></msub><mo>=</mo><munderover><mo>∑</mo><mrow><mi>i</mi><mo>=</mo><mn>2</mn></mrow><mi>v</mi></munderover><mi>i</mi><msub><mi>v</mi><mrow><mi>i</mi><mo>,</mo><mi>e</mi><mi>q</mi></mrow></msub><mi>.</mi></mrow><annotation encoding="application/x-tex">\begin{equation}
R_{multi} = \sum_{i=2}^{v} iv_{i,eq}.
\end{equation}</annotation></semantics></math>
<h2 id="calculations">Calculations</h2>
<h3 id="parameters-and-assumptions">Parameters and Assumptions</h3>
<p>Association constants for all combinations of IgG and FcγR were obtained from previous experimental measurements<span class="citation" data-cites="Bruhns:2009kg"><sup><a href="#ref-Bruhns:2009kg">3</a></sup></span>. In each replicate of Lux's assay, cells were coincubated with 5 g/ml TNP-X-BSA. Because the molar masses of a 2,4,6-trinitrophenyl groups and of BSA are approximately 173 Da and 66430 Da, respectively, we represented the molar concentrations of TNP-4-BSA and TNP-26-BSA as 74 nM and 70 nM. For the sake of parsimony, we assumed that the cross-linking constant <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math> is identical for all combinations of FcγR and IgG. We also assumed that there was a conversion factor between the number of ICs bound and MFI for both TNP-4-BSA and TNP-26-BSA and that these two conversion factors were likely different. Lastly, we assumed that, due to steric effects, the effective avidities of TNP-4-BSA and (especially) TNP-26-BSA might be different that their actual avidities. This required us, in total, to fit 11 parameters: the total expression level <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>R</mi><mrow><mi>t</mi><mi>o</mi><mi>t</mi></mrow></msub><annotation encoding="application/x-tex">R_{tot}</annotation></semantics></math> for each FcγR, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math>, conversion factors from ligand bound to MFI for both TNP-BSAs (<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>c</mi><mn>4</mn></msub><annotation encoding="application/x-tex">c_{4}</annotation></semantics></math> and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>c</mi><mn>26</mn></msub><annotation encoding="application/x-tex">c_{26}</annotation></semantics></math>, respectively), and effective avidities for both TNP-BSAs (<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>f</mi><mn>4</mn></msub><annotation encoding="application/x-tex">f_{4}</annotation></semantics></math> and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>f</mi><mn>26</mn></msub><annotation encoding="application/x-tex">f_{26}</annotation></semantics></math>, respectively).</p>
<p>Based on the order of magnitude of cross-linking constant values presented in the aforementioned paper by Stone et al., we assumed that our cross-linking constant <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>K</mi><mi>X</mi></msub><annotation encoding="application/x-tex">K_X</annotation></semantics></math> should be between</p>
<h3 id="model-fitting">Model Fitting</h3>
<p>We fit the aforementioned parameters by minimizing a log-likelihood function of a form similar to that presented by Kitagawa (1986). We assume that the standard error of MFI for any combination of FcγR, IgG, and IC (TNP-4-BSA or TNP-26-BSA) is proportional to the mean of the normalized samples from trials involving that combination of conditions. Therefore, as opposed to fitting a standard error <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>σ</mi><annotation encoding="application/x-tex">\sigma</annotation></semantics></math> for each combination of FcγR, IgG, and IC, we fit a standard error coefficient <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msup><mi>σ</mi><mo>*</mo></msup><annotation encoding="application/x-tex">\sigma^*</annotation></semantics></math> for each combination, which, when multiplied by the mean of the corresponding trial sample, equals the standard deviation of the error for that combination. Therefore, we assume that the likelihood function of any set of parameters granted a specific combination <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>i</mi><annotation encoding="application/x-tex">i</annotation></semantics></math> of FcγR, IgG, and IC is of the form:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mstyle mathvariant="script"><mi>ℒ</mi></mstyle><mo stretchy="false" form="prefix">(</mo><msub><mi>K</mi><mi>X</mi></msub><mo>,</mo><msub><mi>c</mi><mn>4</mn></msub><mo>,</mo><msub><mi>c</mi><mn>26</mn></msub><mo>,</mo><msub><mi>f</mi><mn>4</mn></msub><mo>,</mo><msub><mi>f</mi><mn>26</mn></msub><mo>,</mo><msup><mi>σ</mi><mo>*</mo></msup><mo stretchy="false" form="prefix">|</mo><mi>i</mi><mo stretchy="false" form="postfix">)</mo><mo>=</mo><munderover><mo>∏</mo><mrow><mi>j</mi><mo>=</mo><mn>1</mn></mrow><msub><mi>n</mi><mi>i</mi></msub></munderover><mrow><mo stretchy="false" form="prefix">(</mo><msup><mi>σ</mi><mo>*</mo></msup><msub><mi>μ</mi><mi>i</mi></msub><msqrt><mrow><mn>2</mn><mi>π</mi></mrow></msqrt><msup><mo stretchy="false" form="postfix">)</mo><mrow><mo>−</mo><mn>1</mn></mrow></msup><mo>exp</mo><mrow><mo minsize="1.8" maxsize="1.8" stretchy="false" form="prefix">(</mo><mfrac><mrow><mo stretchy="false" form="prefix">(</mo><msub><mi>y</mi><mrow><mi>i</mi><mi>j</mi></mrow></msub><mo>−</mo><msub><mi>c</mi><mi>i</mi></msub><mi>L</mi><msup><mo stretchy="false" form="postfix">)</mo><mn>2</mn></msup></mrow><mrow><mn>2</mn><mo stretchy="false" form="prefix">(</mo><msup><mi>σ</mi><mo>*</mo></msup><msub><mi>μ</mi><mi>i</mi></msub><msup><mo stretchy="false" form="postfix">)</mo><mn>2</mn></msup></mrow></mfrac><mo minsize="1.8" maxsize="1.8" stretchy="false" form="postfix">)</mo></mrow></mrow></mrow><annotation encoding="application/x-tex"> \mathcal{L}(K_X,c_4,c_{26},f_4,f_{26},\sigma^*|i) = \prod_{j=1}^{n_i}{(\sigma^*\mu_i\sqrt{2\pi})^{-1}\exp{\Big(\frac{(y_{ij}-c_iL)^2}{2(\sigma^*\mu_i)^2}\Big)}} </annotation></semantics></math></p>
<p>where <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>n</mi><mi>i</mi></msub><annotation encoding="application/x-tex">n_i</annotation></semantics></math> is the number of samples from the assay for that particular <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>i</mi><annotation encoding="application/x-tex">i</annotation></semantics></math>, <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>y</mi><mrow><mi>i</mi><mi>j</mi></mrow></msub><annotation encoding="application/x-tex">y_{ij}</annotation></semantics></math> is the <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>j</mi><annotation encoding="application/x-tex">j</annotation></semantics></math> normalized MFI from the sample representing <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>i</mi><annotation encoding="application/x-tex">i</annotation></semantics></math>, and <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>μ</mi><mi>i</mi></msub><annotation encoding="application/x-tex">\mu_i</annotation></semantics></math> is the algebraic mean of the sample representing <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>i</mi><annotation encoding="application/x-tex">i</annotation></semantics></math>. The total log-likelihood, then, for particular a set of parameters is:</p>
<math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mtable><mtr><mtd columnalign="right"><msub><mi>l</mi><mrow><mi>t</mi><mi>o</mi><mi>t</mi><mi>a</mi><mi>l</mi></mrow></msub><mo>=</mo><munder><mo>∑</mo><mi>i</mi></munder><mo>log</mo><mo stretchy="false" form="prefix">(</mo><mstyle mathvariant="script"><mi>ℒ</mi></mstyle><mo stretchy="false" form="prefix">(</mo><msub><mi>R</mi><mrow><mi>t</mi><mi>o</mi><mi>t</mi><mo>,</mo><mi>F</mi><mi>c</mi><mi>γ</mi><mi>R</mi><mi>I</mi><mi>I</mi><mi>I</mi><mi>A</mi><mo>−</mo><mn>158</mn><mi>V</mi></mrow></msub><mo>,</mo><msub><mi>K</mi><mi>X</mi></msub><mo>,</mo><msub><mi>c</mi><mn>4</mn></msub><mo>,</mo><msub><mi>c</mi><mn>26</mn></msub><mo>,</mo><msub><mi>f</mi><mn>4</mn></msub><mo>,</mo><msub><mi>f</mi><mn>26</mn></msub><mo>,</mo><msup><mi>σ</mi><mo>*</mo></msup><mo stretchy="false" form="prefix">|</mo><mi>i</mi><mo stretchy="false" form="postfix">)</mo><mo stretchy="false" form="postfix">)</mo></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{equation}
\begin{split}
l_{total}=\sum_i\log(\mathcal{L}(R_{tot,Fc\gamma RIIIA-158V},K_X,c_4,c_{26},f_4,f_{26},\sigma^*|i))
\end{split}
\end{equation}</annotation></semantics></math>
<p>We integrated under the log-likelihood distribution <math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>l</mi><annotation encoding="application/x-tex">l</annotation></semantics></math> over all twelve parameters listed above using the mhsample implementation of the Metropolis-Hastings algorithm in MATLAB. We sampled 10 million points with using a burn-in length of 1000.</p>
<h1 id="acknowledgements">Acknowledgements</h1>
<p>This work was supported by NIH DP5-OD019815 to A.S.M. <strong>Competing financial interests:</strong> The authors declare no competing financial interests.</p>
<h1 id="author-contributions-statement">Author contributions statement</h1>
<p>A.S.M. conceived the experiment(s), A.S.M. and R.A.R. conducted the experiment(s), A.S.M. and R.A.R. analyzed the results. All authors reviewed the manuscript.</p>
<h1 id="supplement">Supplement</h1>
<table>
<thead>
<tr class="header">
<th style="text-align: left;">FcγR</th>
<th style="text-align: center;">IgG</th>
<th style="text-align: center;">Replicate</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: left;">TNP-4-BSA</td>
<td style="text-align: center;">TNP-26-BSA</td>
<td style="text-align: center;"></td>
</tr>
</tbody>
</table>
<table>
<caption>Table: Raw binding measurements. The original MFIs from the Nimmerjahn Lab's experiment, normalized by replicate. No data was recorded in Replicate 2 for the combination of FcγRIIIA-158V, IgG3, and TNP-4-BSA.</caption>
<thead>
<tr class="header">
<th></th>
<th></th>
<th>1 2</th>
<th style="text-align: right;">3 4</th>
<th style="text-align: right;">1</th>
<th style="text-align: right;">2 3</th>
<th style="text-align: right;">4</th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>FcγRIA</td>
<td>background</td>
<td>113</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">38</td>
<td>6</td>
<td>8</td>
<td>10</td>
</tr>
<tr class="even">
<td>FcγRIA</td>
<td>IgG1</td>
<td>441</td>
<td style="text-align: right;">427</td>
<td style="text-align: right;">784</td>
<td style="text-align: right;">172</td>
<td style="text-align: right;">318</td>
<td>552</td>
<td>900</td>
<td>248</td>
</tr>
<tr class="odd">
<td>FcγRIA</td>
<td>IgG2</td>
<td>440</td>
<td style="text-align: right;">578</td>
<td style="text-align: right;">997</td>
<td style="text-align: right;">176</td>
<td style="text-align: right;">404</td>
<td>392</td>
<td>894</td>
<td>124</td>
</tr>
<tr class="even">
<td>FcγRIA</td>
<td>IgG3</td>
<td>442</td>
<td style="text-align: right;">407</td>
<td style="text-align: right;">905</td>
<td style="text-align: right;">185</td>
<td style="text-align: right;">322</td>
<td>515</td>
<td>957</td>
<td>242</td>
</tr>
<tr class="odd">
<td>FcγRIA</td>
<td>IgG4</td>
<td>388</td>
<td style="text-align: right;">428</td>
<td style="text-align: right;">618</td>
<td style="text-align: right;">139</td>
<td style="text-align: right;">530</td>
<td>431</td>
<td>810</td>
<td>172</td>
</tr>
<tr class="even">
<td>FcγRIIA-131R</td>
<td>background</td>
<td>14</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">18</td>
<td>9</td>
<td>12</td>
<td>12</td>
</tr>
<tr class="odd">
<td>FcγRIIA-131R</td>
<td>IgG1</td>
<td>130</td>
<td style="text-align: right;">177</td>
<td style="text-align: right;">274</td>
<td style="text-align: right;">58</td>
<td style="text-align: right;">266</td>
<td>604</td>
<td>1016</td>
<td>281</td>
</tr>
<tr class="even">
<td>FcγRIIA-131R</td>
<td>IgG2</td>
<td>50</td>
<td style="text-align: right;">23</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">13</td>
<td style="text-align: right;">149</td>
<td>139</td>
<td>381</td>
<td>48</td>
</tr>
<tr class="odd">
<td>FcγRIIA-131R</td>
<td>IgG3</td>
<td>184</td>
<td style="text-align: right;">193</td>
<td style="text-align: right;">408</td>
<td style="text-align: right;">87</td>
<td style="text-align: right;">523</td>
<td>621</td>
<td>1297</td>
<td>281</td>
</tr>
<tr class="even">
<td>FcγRIIA-131R</td>
<td>IgG4</td>
<td>44</td>
<td style="text-align: right;">21</td>
<td style="text-align: right;">29</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">265</td>
<td>151</td>
<td>343</td>
<td>72</td>
</tr>
<tr class="odd">
<td>FcγRIIA-131H</td>
<td>background</td>
<td>38</td>
<td style="text-align: right;">4 4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">53</td>
<td style="text-align: right;">5 5</td>
<td>10</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIA-131H</td>
<td>IgG1 327</td>
<td>308</td>
<td style="text-align: right;">539</td>
<td style="text-align: right;">113</td>
<td style="text-align: right;">660</td>
<td style="text-align: right;">585</td>
<td>1298</td>
<td>377</td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIA-131H</td>
<td>IgG2 277</td>
<td>203</td>
<td style="text-align: right;">174</td>
<td style="text-align: right;">36</td>
<td style="text-align: right;">533</td>
<td style="text-align: right;">394</td>
<td>742</td>
<td>156</td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIA-131H</td>
<td>IgG3 307</td>
<td>334</td>
<td style="text-align: right;">305</td>
<td style="text-align: right;">135</td>
<td style="text-align: right;">421</td>
<td style="text-align: right;">674</td>
<td>1173</td>
<td>405</td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIA-131H</td>
<td>IgG4 148</td>
<td>54</td>
<td style="text-align: right;">6 2</td>
<td style="text-align: right;">0 63</td>
<td style="text-align: right;">0 51</td>
<td style="text-align: right;">7 10</td>
<td>05 1</td>
<td>45</td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIB</td>
<td>background</td>
<td>7 6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">9 7</td>
<td style="text-align: right;">9</td>
<td>10</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIB</td>
<td>IgG1 80</td>
<td>200</td>
<td style="text-align: right;">262</td>
<td style="text-align: right;">30</td>
<td style="text-align: right;">139</td>
<td style="text-align: right;">737</td>
<td>1108</td>
<td>230</td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIB</td>
<td>IgG2 17</td>
<td>27</td>
<td style="text-align: right;">40 8</td>
<td style="text-align: right;">63</td>
<td style="text-align: right;">111</td>
<td style="text-align: right;">260</td>
<td>32</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIB</td>
<td>IgG3 124</td>
<td>231</td>
<td style="text-align: right;">349</td>
<td style="text-align: right;">62</td>
<td style="text-align: right;">442</td>
<td style="text-align: right;">942</td>
<td>746</td>
<td>244</td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIB</td>
<td>IgG4 33</td>
<td>44</td>
<td style="text-align: right;">100</td>
<td style="text-align: right;">21 1</td>
<td style="text-align: right;">83 3</td>
<td style="text-align: right;">31 6</td>
<td>05 6</td>
<td>8</td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIIA-158F</td>
<td>background</td>
<td>7 6</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7 7</td>
<td style="text-align: right;">8</td>
<td>11</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIIA-158F</td>
<td>IgG1 262</td>
<td>676</td>
<td style="text-align: right;">1015</td>
<td style="text-align: right;">269</td>
<td style="text-align: right;">709</td>
<td style="text-align: right;">1333</td>
<td>193</td>
<td>5 69</td>
<td>8</td>
</tr>
<tr class="odd">
<td>FcγRIIIA-158F</td>
<td>IgG2 14</td>
<td>31</td>
<td style="text-align: right;">31 1</td>
<td style="text-align: right;">4 23</td>
<td style="text-align: right;">26</td>
<td style="text-align: right;">68</td>
<td>19</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIIA-158F</td>
<td>IgG3 328</td>
<td>528</td>
<td style="text-align: right;">790</td>
<td style="text-align: right;">267</td>
<td style="text-align: right;">788</td>
<td style="text-align: right;">1668</td>
<td>2628</td>
<td>891</td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIIA-158F</td>
<td>IgG4 9</td>
<td>8 16</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">21</td>
<td style="text-align: right;">46</td>
<td>20</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIIA-158V</td>
<td>background</td>
<td>49</td>
<td style="text-align: right;">8 14</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">49</td>
<td style="text-align: right;">8 9</td>
<td>8</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIIA-158V</td>
<td>IgG1 295</td>
<td>596</td>
<td style="text-align: right;">1016</td>
<td style="text-align: right;">334</td>
<td style="text-align: right;">488</td>
<td style="text-align: right;">813</td>
<td>1330</td>
<td>383</td>
<td></td>
</tr>
<tr class="even">
<td>FcγRIIIA-158V</td>
<td>IgG2 105</td>
<td>186</td>
<td style="text-align: right;">293</td>
<td style="text-align: right;">65</td>
<td style="text-align: right;">177</td>
<td style="text-align: right;">362</td>
<td>573</td>
<td>114</td>
<td></td>
</tr>
<tr class="odd">
<td>FcγRIIIA-158V</td>
<td>IgG3 N/A</td>
<td>623</td>
<td style="text-align: right;">1055</td>
<td style="text-align: right;">365</td>
<td style="text-align: right;">924</td>
<td style="text-align: right;">1317</td>
<td>186</td>
<td>1 67</td>
<td>6</td>
</tr>
<tr class="even">
<td>FcγRIIIA-158V</td>
<td>IgG4 122</td>
<td>136</td>
<td style="text-align: right;">262</td>
<td style="text-align: right;">91</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">558</td>
<td>1026</td>
<td>239</td>
<td></td>
</tr>
</tbody>
</table>
<h1 id="references" class="unnumbered">References</h1>
<div id="refs" class="references">
<div id="ref-Moynihan:2016jb">
<p>1. Moynihan, K. D. <em>et al.</em> Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. <em>Nature Medicine</em> 1–12 (2016).</p>
</div>
<div id="ref-Zhu:2015gy">
<p>2. Zhu, E. F. <em>et al.</em> Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. <em>Cancer Cell</em> <strong>27,</strong> 489–501 (2015).</p>
</div>
<div id="ref-Bruhns:2009kg">
<p>3. Bruhns, P., Iannascoli, B., England, P. &amp; Mancardi, D. A. Specificity and affinity of human Fc<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>γ</mi><annotation encoding="application/x-tex">\gamma</annotation></semantics></math> receptors and their polymorphic variants for human IgG subclasses. <em>Blood</em> (2009).</p>
</div>
<div id="ref-Lux:2013iv">
<p>4. Lux, A., Yu, X., Scanlan, C. N. &amp; Nimmerjahn, F. Impact of immune complex size and glycosylation on IgG binding to human Fc<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>γ</mi><annotation encoding="application/x-tex">\gamma</annotation></semantics></math>Rs. <em>The Journal of Immunology</em> <strong>190,</strong> 4315–4323 (2013).</p>
</div>
<div id="ref-Clynes:2000ga">
<p>5. Clynes, R. A., Towers, T. L., Presta, L. G. &amp; Ravetch, J. V. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. <em>Nature Medicine</em> <strong>6,</strong> 443–446 (2000).</p>
</div>
<div id="ref-Nimmerjahn:2005hu">
<p>6. Nimmerjahn, F. &amp; Ravetch, J. V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. <em>Science</em> <strong>310,</strong> 1510–1512 (2005).</p>
</div>
<div id="ref-Perelson:1980fs">
<p>7. Perelson, A. S. &amp; DeLisi, C. Receptor clustering on a cell surface. I. Theory of receptor cross-linking by ligands bearing two chemically identical functional groups. <em>Mathematical Biosciences</em> <strong>48,</strong> 71–110 (1980).</p>
</div>
<div id="ref-Perelson:1980ds">
<p>8. Perelson, A. S. Receptor clustering on a cell surface. II. theory of receptor cross-linking by ligands bearing two chemically distinct functional groups. <em>Mathematical Biosciences</em> <strong>49,</strong> 87–110 (1980).</p>
</div>
<div id="ref-Hlavacek:1999gb">
<p>9. Hlavacek, W. S., Posner, R. G. &amp; Perelson, A. S. Steric Effects on Multivalent Ligand-Receptor Binding: Exclusion of Ligand Sites by Bound Cell Surface Receptors. <em>Biophysical Journal</em> <strong>76,</strong> 3031–3043 (1999).</p>
</div>
<div id="ref-Stone:2001fm">
<p>10. Stone, J. D., Cochran, J. R. &amp; Stern, L. J. T-Cell Activation by Soluble MHC Oligomers Can Be Described by a Two-Parameter Binding Model. <em>Biophysical Journal</em> <strong>81,</strong> 2547–2557 (2001).</p>
</div>
</div>
</body>
</html>
